Gossamer Bio Inc (NASDAQ: GOSS) is -5.99% lower on its value in year-to-date trading and has touched a low of $0.50 and a high of $1.60 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GOSS stock was last observed hovering at around $0.93 in the last trading session, with the day’s loss setting it -0.07%.
Currently trading at $0.86, the stock is 15.88% and 1.86% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.47 million and changing -7.76% at the moment leaves the stock -5.15% off its SMA200. GOSS registered -16.72% loss for a year compared to 6-month gain of 64.93%. The firm has a 50-day simple moving average (SMA 50) of $0.84646 and a 200-day simple moving average (SMA200) of $0.90703.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 11.40% loss in the last 1 month and extending the period to 3 months gives it a -4.55%, and is 11.91% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.89% over the week and 8.48% over the month.
Gossamer Bio Inc (GOSS) has around 135 employees, a market worth around $198.65M and $105.32M in sales. Profit margin for the company is -68.03%. Distance from 52-week low is 71.80% and -46.39% from its 52-week high. The company has generated returns on investments over the last 12 months (-27.99%).
with sales reaching $6.83M over the same period.The EPS is expected to grow by 76.06% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Gossamer Bio Inc (GOSS) Top Institutional Holders
112.0 institutions hold shares in Gossamer Bio Inc (GOSS), with institutional investors hold 80.13% of the company’s shares. The shares outstanding are 226.60M, and float is at 174.03M with Short Float at 3.66%. Institutions hold 77.46% of the Float.
The top institutional shareholder in the company is NEA MANAGEMENT COMPANY, LLC with over 18.09 million shares valued at $16.3 million. The investor’s holdings represent 8.0152% of the GOSS Shares outstanding. As of 2024-06-30, the second largest holder is ARTAL GROUP S.A. with 13.31 million shares valued at $11.99 million to account for 5.8958 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 11.76 million shares representing 5.2098% and valued at over $10.59 million, while OCTAGON CAPITAL ADVISORS LP holds 4.0702 of the shares totaling 9.19 million with a market value of $8.28 million.
Gossamer Bio Inc (GOSS) Insider Activity
The most recent transaction is an insider sale by Aranda Richard, the company’s Chief Medical Officer. SEC filings show that Aranda Richard sold 1,908 shares of the company’s common stock on Jun 24 ’24 at a price of $0.66 per share for a total of $1260.0. Following the sale, the insider now owns 0.2 million shares.
Gossamer Bio Inc disclosed in a document filed with the SEC on Jun 21 ’24 that Hasnain Faheem (President & CEO) bought a total of 372,000 shares of the company’s common stock. The trade occurred on Jun 21 ’24 and was made at $0.67 per share for $0.25 million. Following the transaction, the insider now directly holds 5.41 million shares of the GOSS stock.
Still, SEC filings show that on Jun 18 ’24, Giraudo Bryan (COO/CFO) acquired 100,000 shares at an average price of $0.59 for $59110.0. The insider now directly holds 480,010 shares of Gossamer Bio Inc (GOSS).
